Versions Compared

Old Version 12

changes.mady.by.user Wendy Dobson

Saved on

compared with

New Version Current

changes.mady.by.user Kerry Robson

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Image Modified


paper
Project Scope

This project team will create a

White Paper with recommendations for listings to include in Clinical Study Reports based on shared learning from cross-industry participants, to address changes in data availability over time.



Project LeadsEmails
Nancy Brucken nbrucken@csg-inc
Mercy Navarro (Genentech)navarrom@gene.com
Mercy Navarro 
 
Nancy Brucken (IQVIA)

nancy.brucken@iqvia

navarrom@gene

.com

 

Wendy Dobson
Katie Warren (PHUSE Project
Manager
Assistant)
wendy@phuse
katie@phuse.global


Objectives & DeliverablesTimelines
White Paper providing recommendations for listings to include CSRs and submissions (if any), with a summary of example alternatives to static listings

Public review - Q12021

Final paper - Q22021

PharmaSUG final paper

Q2 2022
PharmaSUG slidesQ2 2022

PHUSE US Connect poster

Q2 2022


Status
colourBlue
titleCURRENT STATUS
Q3/4 2022 

  • Received journal submission response with comments to be addressed before publication
  • White Paper published on the PHUSE website



Project MembersOrganisation
Anna LeathEli Lilly
Project MembersCompany
Kim MusgraveAmgen
Kirthi RangarajuPfizer
Maria DaltonGSK
Mary NilssonEli Lilly

Status
colourBlue
titleCurrent Status
 Q42020

Team recently presented at CSS. Bi-weekly meetings now established    
Raj PhadtareCorvus Pharma